PERRIS, Roberto
 Distribuzione geografica
Continente #
AS - Asia 7.712
NA - Nord America 7.274
EU - Europa 4.279
SA - Sud America 1.032
AF - Africa 346
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 20.660
Nazione #
US - Stati Uniti d'America 7.095
SG - Singapore 2.839
CN - Cina 2.029
VN - Vietnam 1.155
IT - Italia 836
IE - Irlanda 830
BR - Brasile 821
SE - Svezia 667
HK - Hong Kong 586
FI - Finlandia 408
TR - Turchia 373
DE - Germania 348
NL - Olanda 269
FR - Francia 264
ZA - Sudafrica 264
BD - Bangladesh 256
UA - Ucraina 233
GB - Regno Unito 124
CA - Canada 102
AR - Argentina 90
RU - Federazione Russa 75
IN - India 71
JP - Giappone 60
IQ - Iraq 50
MX - Messico 39
AT - Austria 30
BE - Belgio 29
KR - Corea 29
PH - Filippine 28
BG - Bulgaria 27
EC - Ecuador 27
PK - Pakistan 27
CZ - Repubblica Ceca 26
IR - Iran 25
MA - Marocco 23
VE - Venezuela 23
CO - Colombia 22
EE - Estonia 19
PL - Polonia 19
UZ - Uzbekistan 19
CL - Cile 16
ES - Italia 16
ID - Indonesia 16
PY - Paraguay 15
TH - Thailandia 15
TN - Tunisia 14
JO - Giordania 13
RO - Romania 13
DZ - Algeria 11
MY - Malesia 11
NP - Nepal 11
LB - Libano 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
TW - Taiwan 9
AZ - Azerbaigian 8
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
PE - Perù 8
JM - Giamaica 7
KZ - Kazakistan 7
AU - Australia 6
CI - Costa d'Avorio 6
CR - Costa Rica 6
IL - Israele 6
PA - Panama 6
PT - Portogallo 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
UY - Uruguay 5
XK - ???statistics.table.value.countryCode.XK??? 5
BH - Bahrain 4
EU - Europa 4
KG - Kirghizistan 4
NG - Nigeria 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
LK - Sri Lanka 3
QA - Qatar 3
SI - Slovenia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
LU - Lussemburgo 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
SC - Seychelles 2
Totale 20.635
Città #
Singapore 1.250
San Jose 851
Dublin 830
Chandler 769
Ashburn 699
Hong Kong 561
Beijing 456
Dearborn 424
Santa Clara 421
Ho Chi Minh City 376
Izmir 330
Nanjing 272
Dallas 259
Jacksonville 259
Boardman 256
Johannesburg 247
Hanoi 245
Princeton 212
Lauterbourg 190
Wilmington 166
Ann Arbor 154
Parma 133
New York 116
Los Angeles 108
Helsinki 87
Shanghai 86
Shenyang 86
Hefei 85
Nanchang 81
San Mateo 81
Buffalo 79
Munich 77
Jinan 73
Columbus 69
São Paulo 68
Hebei 67
Milan 61
Tianjin 57
Sant'Ilario d'Enza 56
Haiphong 53
Tokyo 53
Bologna 52
Da Nang 52
Kunming 52
Seattle 52
Jiaxing 47
Moscow 47
Toronto 47
Marseille 43
Changsha 38
Stockholm 34
Council Bluffs 33
Düsseldorf 30
Guangzhou 30
Norwalk 30
Rio de Janeiro 28
Des Moines 27
Bremen 26
Brussels 26
Frankfurt am Main 25
London 25
Modena 24
Vienna 24
Houston 23
The Dalles 23
Woodbridge 23
Zhengzhou 23
Atlanta 22
Belo Horizonte 22
Biên Hòa 21
Borås 21
Chicago 21
Falls Church 21
Florence 21
Montreal 21
Turku 21
Brno 20
Brooklyn 20
Hải Dương 20
Rome 20
Amsterdam 19
Baghdad 19
Ningbo 19
Nuremberg 19
Hangzhou 18
Orem 18
Brescia 17
Porto Alegre 17
Tashkent 17
Brasília 16
Haikou 16
Pittsburgh 15
Redondo Beach 15
Curitiba 14
Fremont 14
Taizhou 14
Boston 13
Can Tho 13
Fuzhou 13
Mestre 13
Totale 12.277
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 312
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 262
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 255
Pro-apoptotic anti-NG2/CSPG4 monoclonal antibodies for disease therapy 195
A translational perspective of the malignant hematopoietic proteoglycome 193
Antithetic glypican control of cancer growth and dissemination 183
Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target 168
Proteoglycans in metastasis formation and anti-neoplastic therapeutic approaches 159
Drug resistance in higly aggressive acute leukemias is controlled by de novo espressed NG2 proteoglycan acting via modulation of selected transporters 159
Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas 152
Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates 149
Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex 148
Combinare più indizi 148
Differential microRNA expression in osteosarcoma cell with different tumorigenic behaviour 146
Anticorpo monoclonale per diagnosi e trattamento di tumori canini 145
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential 144
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 144
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 142
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the Neomark Project interim results. 141
Antithetic roles of proteoglycans in cancer 139
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 138
Proteoglycans as Potential Markers of the Biological Behaviour of Head and Neck Carcinomas: Interim Results of a Multicenter Italian Project. 135
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 132
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 132
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 129
Glypican and Syndecan: tumor growth regulators 126
Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. 125
Molecular cloning, sequencing, tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP) 124
Neurogenic potential of human mesenchymal stem cells revised by time-lapse vide-microscopy and wide scale gene expression profiling 124
Approaching the Proteoglycome: Molecular interactions of proteoglycans and their functional output 124
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. 123
Differential microRNA expression in sarcomas with diverse metastatic potential 123
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the NeoMark project results. 123
An intimate interplay between precocious, migrating pericytes and endothelialcells governs human fetal brain angiogenesis 122
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark project’s interim results. 122
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 122
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential. 122
Proteoglycans as potential markers of the biological behaviour of head and neck carcinomas: Interim Results of a Multicenter Italian Project. 121
Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation 121
Evaluation of immunohistochemical and biomolecular parameters as markers of the biological behaviour of head and neck carcinomas: preliminary results of a multicenter Italian Project. 121
a4b1/a4b7-mediated interaction of human B cell lymphomas with fibronectin involves recognition of multiple cooperating sites 120
Differential approach to define MicroRNA expression patterns in osteosarcomas 120
Aggrecan is expressed by radial glia in the developing human brain 118
MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line 118
Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters 117
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets 117
Theranostic impact of NG2/CSPG4 proteoglycan in cancer 117
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 117
Analysis of a novel polylactosamine-containing antigen associated with colon carcinomas. 114
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development 113
Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis 112
Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm 111
Blood clotting in space 110
Analysis of tissue-bound and circulating antigens of the poly-N-lactosamine series in colon carcinomas 109
Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth 108
Structural and compositional divergencies in the extracellular matrix encountered by neural crest cells in the white mutant axolotl embryo 106
The angiogenic asset of soft tissue sarcomas: A new tool to discover new therapeutic targets 105
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses in disease therapy 105
Tumor cell NG2 proteoglycan controls cancer progression through its interaction with host Collagen type VI 104
Bidirectional induction of the cognate receptor-ligand α4/VCAM-1 pair defines a novel mechanism of tumor intravasation 104
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 103
Improving fluorescence-based assays for the in vitro analysis of cell adhesion and migration 103
Paving the path for invasion: The polyedric role of LASP1 in cancer 102
A novel laminin complex is a potent ligand for human leukocytes 102
Cell origin of tumours and the persistence of cancer propagatine cells in tumour lesions 101
Proteoglycans in the control of tumor growth and metastasis formation 101
Centrifugal assay for fluorescence-based cell adhesion adapted to the analysis of ex vivo cells and capable of determining relative binding strengths 101
PRO-APOPTOTIC ANTI-NG2/CSPG4 ANTIBODIES AND THEIR USES FOR DISEASE THERAPY 99
MicroRNA expression patterns in osteosarcomas and their potential role in tumour progression 99
Morphogenesis-related distribution of intermediate filaments in developing human mesonephros and metanephros 98
Attachment of tumor and normal cell lines to collagen type VI involves recognition of the globular domains 98
Role of the 4ß7 integrin in the interaction of murine leukemic cells with fibronectin after the in vivo progression from a T-cell lymphoma to leukemic phenotype 98
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion 98
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 97
Pattern d’espressione di microRNAs in cellule di osteosarcoma ed il loro potenziale ruolo nella progressione tumorale 97
Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts 96
Collagen type VI in neural crest development: distribution in situ and interaction with cells in vitro 96
Laminin-10 is a primary subendothelial ligand for tumor leukocytes 96
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis 96
Proteomic and post-proteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinoma 95
Sonic hedgehog regulates the position of the trigeminal ganglia 95
Localization and expression of Cartilage Oligomeric Matrix Protein (COMP) by human rheumatoid and osteoarthritic synovium and cartilage 95
Preferential locomotion of leukemic cells towards laminin isoforms 8, and 10 94
Embryonic extracellular matrix adsorbed in vivo onto microcarriers induces phenotypic expression in cultured neural crest cells 94
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP9 93
"Destemming" cancer stem cells. 93
MicroRNA expression patterns in osteosarcoma 93
MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93 93
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis 93
Instructive induction or permissive activation? Differentiation of ectodermal cells isolated from the axolotl blastula 92
Anticorpo biparatopico diretto verso NG2/CSPG4 e i suoi usi 91
Fluorescence-based assays for in vitro analysis of cell adhesion and migration 91
Molecular mechanisms of avian neural crest cell migration on fibronectin and laminin 91
Tumour dormancy induced by overexpression of PG-M/versican G1 domain in soft tissue sarcomas 90
CAFCA - A novel centrifugal assay for fluorescence-based cell adhesion for the quantitative analysis of cell-cell and cell-substratum adhesion of freshly isolated normal and tumor leukocytes. 90
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia 90
Fluorescence assays to study cell adhesion and migration in vitro 89
INTEGRATION OF CLINICAL, HISTOPATHOLOGICAL, RADIOLOGICAL AND BIOMOLECULAR DATA FOR PREDICTION OF ORAL CANCER RECURRENCE: THE NEOMARK PROJECT'S FIRST REPORT. 89
Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof 89
Stimulation of initial neural crest cell migration in the axolotl embryo by tissue grafts and extracellular matrix transplanted on microcarriers 89
Totale 12.048
Categoria #
all - tutte 81.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022771 8 17 7 22 15 15 51 109 39 57 79 352
2022/20233.042 422 284 136 229 247 320 13 195 1.049 23 104 20
2023/20241.085 66 101 41 27 122 223 41 76 30 79 58 221
2024/20253.872 89 252 262 194 478 385 129 107 549 397 282 748
2025/20268.083 620 844 902 675 1.180 386 894 337 1.051 563 423 208
2026/2027125 125 0 0 0 0 0 0 0 0 0 0 0
Totale 20.879